- Metoclopramide in the Treatment of Diabetic Gastroparesis
Risk factors for extrapyramidal reactions from metoclopramide include diabetes mellitus Unfortunately, this is also a risk factor for developing gastroparesis and metoclopramide is the only FDA
- Novel Drug Safe, Effective for Acute Schizophrenia - Medscape
The novel PDE10A inhibitor CPL #039;36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests
- Depression, Extrapyramidal Symptoms, Dementia and an . . . - Medscape
The extrapyramidal symptoms have disappeared Introduction The diagnosis of Parkinson's disease (PD) is, most of the times, clinical with sensitivity of 88% and specificity 78%
- Ending Long-term Anticholinergic Use: It Can Be Done - Medscape
Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients with serious mental
- Untreated Tardive Dyskinesia Hinders Use of Antipsychotics - Medscape
Tardive dyskinesia, often underdiagnosed and undertreated, hinders patient adherence to antipsychotics, affecting mental health treatment and caregivers' well-being, reports Dr Daniel Kremens
- Positive Phase 3 Results for Antipsychotic in Schizophrenia - Medscape
The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal EMERGENT-2 trial
- Olanzapine Associated With Lower Rate of Extrapyramidal . . . - Medscape
Oct 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large prospective trial
- Recognizing Symptoms and Suffering in Hyperemesis Gravidarum - Medscape
PARIS — The understanding and management of nausea, vomiting, and hyperemesis gravidarum are progressing "Improving hyperemesis gravidarum treatment begins with recognizing the symptoms and
|